How long can you stay on Imbruvica (ibrutinib)?

Official answer

by Drugs.com

Imbruvica is usually given until disease progression or unacceptable toxicity occurs, or in the case of graft vs host disease, recurrence of an underlying malignancy.

The average duration of Imbruvica therapy in CLL clinical trials has been around 41 months (range, 2–51 months).

Imbruvica (ibrutinib) is usually continued indefinitely if it is being well tolerated, there is limited disease progression, and toxicity has not occurred.

In some people, very good partial clinical responses may occur within three to six months.

However, most people are kept on Imbruvica indefinitely regardless of clinical response. This is a common treatment strategy for people with certain types of leukemia and solid tumors because often when the treatment agent is stopped, symptoms can reappear and lymph nodes enlarge within a relatively short period, particularly if patients have not been taking Imbruvica for very long or if they have tried many other previous treatments.

The average duration of Imbruvica therapy in clinical trials has been around 41 months (range, 2–51 months). In people who have stopped Imbruvica, the average survival after treatment discontinuation was 8 months.

What is the dosage of Imbruvica?

The recommended starting dose for Imbruvica varies depending on the condition being treated, but examples include:

Waldenstrom's macroglobulinemia: 420mg once daily

Chronic lymphocytic leukemia (CLL): 420mg once daily

Small lymphocytic lymphoma: 420mg once daily

Chronic graft-versus-host disease: 420mg once daily.

Dosages may need reducing if toxicities occur. Imbruvica is usually given until disease progression or unacceptable toxicity occurs, or in the case of graft vs host disease, recurrence of an underlying malignancy.

What are the most common side effects with Imbruvica?

The most common side effects reported with Imbruvica include:

Back pain

Bruising

Chest pain, atrial fibrillation, atrial flutter

Diarrhea

Heartburn

High blood pressure

Infection

Lowered blood counts

Muscle aches

Tiredness

Blood in the urine.

These are typically noted more at the beginning of therapy, but for most people, they resolve quickly with time and are often non-existent within 2-3 months. Older people are more at risk of side effects including bruising. In general, Imbruvica is usually well tolerated.

What is Imbruvica?

Imbruvica is a targeted medicine that works by inhibiting the enzyme Bruton tyrosine kinase (BTK), which is part of a crucial signaling pathway in certain cancers, especially B-cell leukemias and lymphomas.

By blocking this pathway Imbruvica triggers the death of cancer cells. Imbruvica may be used in the treatment of

Waldenstrom's macroglobulinemia

Chronic lymphocytic leukemia

Small lymphocytic lymphoma.

Imbruvica may also be used to treat chronic graft-versus-host disease.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.